ANGO vs EQIX · rev $292.5M vs P/E 79, rev $9.22B
AngioDynamics Inc (ANGO) versus Equinix Inc (EQIX) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported EQIX revenue for 2025-12-31 was $9.22B. Net income was $1.35B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
ANGO currently screens at market cap $378.5M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Not investment advice. Open the ANGO and EQIX stock pages for the full models.
Not investment advice.